semaglutide
Commercial- Indications
- Obesity, Weight management
Company intelligence / Profile preview
Belle Health has launched its flagship mobile application ("Belle App") to help women track cycles and manage hormonal health. The company’s app-based cognitive-behavioral therapy program for premenstrual disorders entered clinical trials in early 2024. Early results are pending; the study aims to demonstrate improved quality of life through digital interventions. The "Belle Ring" wearable device remains under development.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Belle Health.